Table 2. The relationship between BCMA expression level and clinicopathologic feature.
| Clinicopathologic feature | Cases (n) | BCMA | P value | |
|---|---|---|---|---|
| Low-expression (n=) | High-expression (n=) | |||
| Age | ||||
| ≤60 | 32 | 14 | 18 | 0.0878 |
| >60 | 16 | 3 | 13 | |
| Sex | ||||
| male | 31 | 15 | 16 | 0.0921 |
| female | 17 | 3 | 14 | |
| Grades | ||||
| I-II | 19 | 5 | 14 | 0.7056 |
| III | 10 | 2 | 8 | |
| Pathological Classification | ||||
| adenocarcinoma | 10 | 1 | 9 | 0.3451 |
| squamous cell carcinoma | 16 | 4 | 12 | |
| Lymph-node metastasis | ||||
| with | 16 | 4 | 12 | 0.942 |
| without | 25 | 6 | 19 | |